A large, prospective, multicentre study of left main PCI using a latest-generation zotarolimus-eluting stent: the ROLEX study

Giuseppe Tarantini, Luca Nai Fovino, Ferdinando Varbella, Daniela Trabattoni, Giuseppe Caramanno, Carlo Trani, Nicoletta De Cesare, Giovanni Esposito, Matteo Montorfano, Carmine Musto, Andrea Picchi, Imad Sheiban, Valeria Gasparetto, Flavio L Ribichini, Francesco Cardaioli, Salvatore Saccà, Enrico Cerrato, Massimo Napodano, Matteo Martinato, Danila AzzolinaGiuseppe Andò, Antonio Mugnolo, Marco Caruso, Roberta Rossini, Enrico Passamonti, Rui Campante Teles, Stefano Rigattieri, Dario Gregori, Corrado Tamburino, Francesco Burzotta

Research output: Contribution to journalArticle

Abstract

Data on left main (LM) percutaneous coronary interventions (PCI) have mostly been obtained in studies using drug-eluting stent (DES) platforms without dedicated large-vessel devices and with limited expansion capability.
Original languageEnglish
Pages (from-to)N/A-N/A
JournalEuroIntervention
Issue number31
DOIs
Publication statusPublished - 2023

All Science Journal Classification (ASJC) codes

  • Cardiology and Cardiovascular Medicine

Keywords

  • cardiovascular disease
  • heart disease
  • pci
  • stent

Fingerprint

Dive into the research topics of 'A large, prospective, multicentre study of left main PCI using a latest-generation zotarolimus-eluting stent: the ROLEX study'. Together they form a unique fingerprint.

Cite this